Washington Trust Bank’s Dare Bioscience DARE Stock Holding History

Washington Trust Bank’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2	Closed	–	–	779
2017 Q4	$0	Buy	+2	New	+$64	﹤0.01%	731

Other funds holding DARE

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Washington Trust Bank's DARE Position: Q1 2018 in Review

Washington Trust Bank sold out of Dare Bioscience (DARE) in Q1 2018, closing a stake of 2 shares.

Washington Trust Bank first reported a position in DARE in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 15 funds tracked by Wall St. Rank hold DARE as of Q1 2018.

Washington Trust Bank reported no remaining Dare Bioscience position as of Q1 2018 after selling out during the quarter.
Washington Trust Bank sold 2 Dare Bioscience shares in Q1 2018.
Washington Trust Bank first reported a position in Dare Bioscience in Q4 2017 and held it in 1 quarter.
Washington Trust Bank's Dare Bioscience position peaked at $0 in Q4 2017.
15 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2018.

Based on Washington Trust Bank's 13F filing for Q1 2018, filed 3 Apr 2018.